Document Detail


On the road to combinations of targeted therapies: PPM1H phosphatase as a suppressor of trastuzumab resistance.
MedLine Citation:
PMID:  22586608     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Lee-Hoeflich and colleagues use RNA interference screening to identify the serine/threonine phosphatase PPM1H as an inhibitor of trastuzumab resistance in vitro. This finding extends the molecular portrait of trastuzumab-resistant cells and provides a rationale when searching for potential therapeutic targets among regulators of PPM1H and/or its substrates.
Authors:
Nicola Aceto; Mohamed Bentires-Alj
Related Documents :
22830638 - Co-infection by two linezolid-resistant coagulase-negative staphylococci with two diffe...
3702598 - Are alzheimer neurofibrillary tangles insoluble polymers?
3305458 - The effect of sodium chloride and temperature on the rate and extent of growth of clost...
19388558 - Heat resistance of dermatophyte's conidiospores from athletes kits stored in nigerian u...
22830638 - Co-infection by two linezolid-resistant coagulase-negative staphylococci with two diffe...
23006758 - Comparison of genospecies and antimicrobial resistance profiles of isolates in the acin...
Publication Detail:
Type:  Comment; Journal Article    
Journal Detail:
Title:  Cancer discovery     Volume:  1     ISSN:  2159-8290     ISO Abbreviation:  Cancer Discov     Publication Date:  2011 Sep 
Date Detail:
Created Date:  2012-05-15     Completed Date:  2012-11-21     Revised Date:  2013-05-08    
Medline Journal Info:
Nlm Unique ID:  101561693     Medline TA:  Cancer Discov     Country:  United States    
Other Details:
Languages:  eng     Pagination:  285-6     Citation Subset:  IM    
Copyright Information:
©2011 AACR.
Affiliation:
Friedrich Miescher Institute for Biomedical Research, Basel, Switzerland. bentires@fmi.ch
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Antibodies, Monoclonal, Humanized / pharmacology*
Cyclin-Dependent Kinase Inhibitor p27 / genetics*
Female
Humans
Phosphoprotein Phosphatases / genetics*,  metabolism*
Chemical
Reg. No./Substance:
0/Antibodies, Monoclonal, Humanized; 147604-94-2/Cyclin-Dependent Kinase Inhibitor p27; EC 3.1.3.16/PPM1H protein, human; EC 3.1.3.16/Phosphoprotein Phosphatases; P188ANX8CK/trastuzumab
Comments/Corrections
Comment On:
Cancer Discov. 2011 Sep;1(4):326-37   [PMID:  22586611 ]

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Methazolamide is a new hepatic insulin sensitizer that lowers blood glucose in vivo.
Next Document:  The Potential Benefits of BIM in the Further Pursuit of Biomarker Discovery in Cancer Therapeutics.